Butyrate supplement for Gulf War illness symptoms
Part of Mental health clinical trials.
This Phase 2 study tests whether a calcium–magnesium butyrate supplement can reduce symptoms of Gulf War Illness (GWI), especially by targeting gut and immune-related pathways. You may be eligible if you’re a Gulf War–era veteran with moderate-to-severe physical symptoms and no conditions or medicines that could explain them instead.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a Gulf War–era veteran and your age is 40 to 70
- Your Gulf War Illness diagnosis matches standard CDC and Kansas criteria
- Your physical symptoms are moderate to severe based on a questionnaire (VSF36 physical domain score under 30/100)
- You do not have another medical condition that could explain your symptoms
- You must not have certain untreated mental health conditions (like schizophrenia, bipolar disorder, delusional disorders, dementia)
- You can’t be actively using alcohol or drugs, and you must not have major organ failure, certain inflammatory autoimmune diseases, or a transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a type of brain stimulation (repeated transcranial magnetic stimulation, or rTMS) can help reduce headaches and body pain in veterans with Gulf War Illness. If you are a Gulf War veteran with ongoing moderate-to-severe pain, this trial could help find a new way to manage your symptoms.
This study looks at what’s driving Gulf War illness, focusing on gut symptoms like belly pain, diarrhea, and bloating. It may help researchers test approaches aimed at gut barrier function in eligible veterans.
This Phase 3 study tests whether following a study diet can improve symptoms of Gulf War illness. It may help people by confirming whether diet changes are an effective treatment.
This trial tests whether Bacopa (a herbal supplement) can improve symptoms of Gulf War Illness (GWI). You may be eligible if you served in the Gulf War and still have ongoing, hard-to-explain fatigue and related symptoms.
This Phase 2 study tests whether resistant potato starch can improve Gulf War illness (GWI), especially gut symptoms and fatigue, in older adults. You may be asked to follow a study plan and provide stool samples, while avoiding certain medications and recent infections.
This trial studies whether nicotinamide riboside (a vitamin-like substance related to vitamin B3) can improve symptoms of Gulf War illness in eligible Gulf War veterans. If you qualify, you may be asked to take the supplement and complete symptom assessments during the study.
Hear when a new Gulf War Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.